Panton-Valentine leukocidin is expressed at toxic levels in human skin abscesses

Clinical Microbiology and Infection

Volumn 14, Issue 12, 2008, Pages 1180-1183

  Badiou, C ^a   Dumitrescu, O ^a   Croze, M ^a   Gillet, Y ^a,b   Dohin, B ^b   Slayman, D H ^b   Allaouchiche, B ^b   Etienne, J ^a   Vandenesch, F ^a   Lina, Gerard ^a  

^a UNIVERSITÉ DE LYON   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

ELISA; Panton Valentine leukocidin; Quantification; Skin infection; Staphylococcus aureus

Indexed keywords

GENOMIC DNA; PANTON VALENTINE LEUKOCIDIN;

ARTICLE; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CELL STRUCTURE; DISEASE DURATION; EDEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PUS; RABBIT; SKIN ABSCESS; SKIN INFECTION; STAPHYLOCOCCUS AUREUS;

ORYCTOLAGUS CUNICULUS; STAPHYLOCOCCUS AUREUS;

EID: 57649188046     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2008.02105.x     Document Type: Article

References (12)

1. Ward PD, Turner WH. Identification of staphylococcal Panton-Valentine leukocidin as a potent dermonecrotic toxin. Infect Immun 1980; 28: 393-397.
2. Vandenesch F, Naimi T, Enright MC et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: Worldwide emergence. Emerg Infect Dis 2003; 9: 978-984.
3. Tristan A, Bes M, Meugnier H et al. Global distribution of Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus, 2006. Emerg Infect Dis 2007; 13: 594-600.
4. Szmigielski S, Sobiczewska E, Prevost G, Monteil H, Colin DA, Jeljaszewicz J. Effect of purified staphylococcal leukocidal toxins on isolated blood polymorphonuclear leukocytes and peritoneal macrophages in vitro. Zentralbl Bakteriol 1998; 288: 383-394.
5. Cribier B, Prevost G, Couppie P, Finck-Barbancon V, Grosshans E, Piemont Y. Staphylococcus aureus leukocidin: A new virulence factor in cutaneous infections? An epidemiological and experimental study. Dermatology 1992; 185: 175-180.
6. Lina G, Piemont Y, Godail-Gamot F et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999; 29: 1128-1132.
7. Gillet Y, Issartel B, Vanhems P et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002; 359: 753-759.
8. Dohin B, Gillet Y, Kohler R et al. Pediatric bone and joint infections caused by Panton-Valentine leukocidin-positive Staphylococcus aureus. Pediatr Infect Dis J 2007; 26: 1042-1048.
9. Gladstone GP, Van Heyningen WE. Staphylococcal leucocidins. Br J Exp Pathol 1957; 38: 123-137.
10. Voyich JM, Otto M, Mathema B et al. Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J Infect Dis 2006; 194: 1761-1770.
11. Hamilton SM, Bryant AE, Karen C et al. In vitro production of Panton-Valentine leukocidin among strains of methicillin-resistant Staphylococcus aureus causing diverse infections. Clin Infect Dis 2007; 45: 1550-1558.
12. Faden H, Rose R, Lesse A, Hollands C, Dryja D, Glick PL. Clinical and molecular characteristics of staphylococcal skin abscesses in children. J Pediatr 2007; 151: 700-703.